13-Valent Pneumococcal Polysaccharide Conjugate Vaccine not checked

CanSino Biologics Inc. · PCV13i

FollowEvery change as it happens, and a Monday email
Stage
in China
Next date
Phase 1/2 trial completes
Trials
2 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“3 doses: 2 months (Dose 1) months (Dose 2), 12-15 months (Booster dose)”In the company’s words, NCT07017777 on ClinicalTrials.gov
Tested for
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections, Streptococcus Pneumoniae Infection
Main trialPhase 3
“This is a Phase 3 randomized, observation-blinded, active-controlled, parallel-group clinical trial designed to evaluate the immunogenicity, safety, and functional antibody response of the experimental vaccine versus the control vaccine in healthy Thailand infants vaccinated at a 2+1 schedule (2 months, 4 months and 12-15 months). The trial will enroll approximately 600 healthy infants aged 2 months (at least 6 weeks) who will be randomly assigned in a 1:1 ratio to receive either the experimental or control vaccine, with 100 in each group (200 in total) randomized to subgroups and subject to…”In the company’s words, NCT07017777 on ClinicalTrials.gov
Other names
PCV13i

Other drugs for Pneumococcal Infections

All 17 drugs for Pneumococcal Infections

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 15 Feb 2027 A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
Phase 1/2Recruiting 24 Nov 2026 Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
Phase 3Completed 30 Mar 2022 Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
Phase 1Completed 23 Jun 2021 Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

Following is part of Solo: you see every change to 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in